Late-Stage Melanoma Results In Economic Burden

In an article published in the March 2010 Archives of Dermatology, researchers report that in the United States, melanoma treatment in late stages of the disease is of significant cost in the population 65 years and older. The incidence of melanoma has risen dramatically over the years, and older white men have the highest rate of mortality…

More: continued here

Filed under: Medicare / Medicaid / Tricare on March 17th, 2010